FMD Vaccine Sources Sought
ID: 12639524SSFMD1Type: Sources Sought
Overview

Buyer

AGRICULTURE, DEPARTMENT OFANIMAL AND PLANT HEALTH INSPECTION SERVICEMRPBS MINNEAPOLIS MNMINNEAPOLIS, MN, 55401, USA

NAICS

Biological Product (except Diagnostic) Manufacturing (325414)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/a5fbfcf1b45a4d8d8c1bf044751972f6/view
Timeline
    Description

    The U.S. Department of Agriculture, specifically the Animal and Plant Health Inspection Service, is conducting a sources-sought notice to identify manufacturers capable of producing, storing, and delivering Foot and Mouth Disease (FMD) vaccines. The USDA aims to enhance its vaccine preparedness by acquiring sufficient quantities of FMD vaccines or vaccine precursors to support response activities in the event of an outbreak, focusing on both inactivated products and novel vaccine platforms. This initiative is critical for safeguarding the U.S. livestock industry from the severe economic and health impacts of FMD, with responses due by 1:00 PM EST on October 25, 2024. Interested parties should submit their capability statements to Amanda Imlach at amanda.imlach@usda.gov and Charmion Harris at charmion.harris@usda.gov.

    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    FMD Vaccine Sources Sought
    Currently viewing
    Sources Sought
    Similar Opportunities
    Bacille Calmette-Guerin (BCG vaccine)
    Active
    Agriculture, Department Of
    The Department of Agriculture, specifically the Animal and Plant Health Inspection Service (APHIS), is seeking to procure the Bacille Calmette-Guerin (BCG) vaccine from Colorado Serum Company, the sole manufacturer capable of supplying this specific strain. This procurement is part of an ongoing study initiated in 2021, aimed at evaluating the effectiveness of BCG vaccination in cattle for combating bovine tuberculosis (bTB) in endemic areas, particularly in Baja California, Mexico. The necessity for a sole source purchase is justified by the unique requirements of the study, including the need for the specific Danish 1331 strain to ensure data consistency and validity. The estimated cost for the vaccine manufacture and shipping is $38,750, and interested parties can contact Jason L. Wilking at Jason.L.Wilking@usda.gov or by phone at 612-336-3210 for further details.
    Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the "Rapid Pandemic Influenza and Emergency Infectious Disease Vaccine Development and Response Capability" through a Special Notice. The objective of this procurement is to establish a long-term partnership focused on developing a flexible and rapid response capability for vaccine development against pandemic influenza and other priority pathogens, initially emphasizing influenza mRNA vaccine development. This initiative is critical for enhancing the nation's preparedness and response to emerging infectious diseases, ensuring readiness to pivot quickly in the face of public health threats. Interested parties can access the full Request for Project Proposals and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    6505--Influenza Virus Vaccine (2025-2026 Flu Season)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of influenza vaccines for the 2025-2026 flu season, with a focus on both quadrivalent and trivalent formulations. The procurement aims to secure reliable vaccine supplies for various government healthcare facilities, including the VA, Bureau of Prisons, and Indian Health Service sites, ensuring compliance with FDA guidelines and the Drug Supply Chain Security Act (DSCSA). This initiative underscores the government's commitment to public health and veteran care, with contracts structured as firm-fixed-price agreements that encourage competitive pricing through a Provisional Federal Ceiling Price (FCP). Interested contractors should contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further details.
    Injectable Influenza Vaccine
    Active
    Dept Of Defense
    The Department of Defense, through the Defense Logistics Agency Troop Support, is soliciting proposals for the procurement of an Injectable Influenza Vaccine under solicitation number SPE2DP24R0003. This opportunity aims to secure a reliable supply of influenza vaccines, which are critical for maintaining the health and readiness of military personnel. The vaccines will be utilized to protect service members from influenza, thereby ensuring operational effectiveness during flu seasons. Interested vendors can reach out to Kevin Weintraub at kevin.weintraub@dla.mil or 215-737-8600, or Theresa Rucci at Theresa.Rucci@dla.mil or 215-737-5768 for further details regarding the solicitation process.
    Center for Veterinary Medicine Assistance with Diagnostic sample collection and Subject Matter Expertise for Vet- LIRN Proficiency Exercises and Consumer Complaint Follow-up
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Food and Drug Administration (FDA), is seeking qualified contractors to assist with diagnostic sample collection and provide subject matter expertise for the Veterinary Laboratory Investigation and Response Network (Vet-LIRN) Proficiency Exercises and consumer complaint follow-up. The contract aims to enhance veterinary drug safety and public health protection by obtaining services that include the collection and testing of diagnostic samples, as well as expert consultation for proficiency tests and interlaboratory comparison exercises. This initiative is crucial for ensuring the reliability of diagnostic testing and compliance with accreditation standards in veterinary medicine. Interested parties must submit their proposals by October 3, 2024, with the contract expected to span a base year and four one-year option periods, beginning October 31, 2024. For inquiries, contact Nicholas Bisher at Nicholas.Bisher@fda.hhs.gov.
    Supplement 210 to the AMS Master Solicitation for the Purchase of Miscellaneous Beef Items for Distribution
    Active
    Agriculture, Department Of
    The US Department of Agriculture's Agricultural Marketing Service (AMS) has issued an updated Supplement 210 as part of its Master Solicitation for the procurement of frozen miscellaneous beef items for federal food and nutrition assistance programs. The focus is on purchasing beef roasts and diced beef from qualified suppliers. This opportunity is primarily aimed at ensuring an adequate supply of beef products that adhere to specific quality, safety, and compliance standards. The AMS seeks to engage suppliers who can meet these criteria while also adhering to humane animal handling practices and food defense requirements. Scope of Work The key tasks for the successful awardee will involve: Supplying frozen beef roasts and diced beef that meet the specified standards, including meat component, grade, and pathogen intervention requirements. Adhering to detailed harvesting, packaging, and labeling instructions, ensuring product integrity and safety. Delivering the beef items under specific temperature requirements and with appropriate sealing and labeling to ensure security and compliance. Providing a warranty, complaint resolution procedures, and a mechanism to prevent the delivery of non-conforming products. Bearing the cost of any audits or certification processes required for contract compliance. Eligibility Criteria Potential applicants should possess the capabilities to meet the extensive requirements outlined in the Federal Purchase Program Specification (FPPS). This includes the ability to harvest, process, and supply beef products that align with the specific standards detailed in the solicitation. Experience in working with the USDA and knowledge of its regulations and standards would be a distinct advantage. Funding and Contract Details The contract type and estimated funding associated with this opportunity were not provided. However, the solicitation indicates that the USDA intends to procure a significant quantity of frozen beef items over an extended period. Applicants should factor in the potential costs of compliance with the extensive requirements outlined in the FPPS. Submission Process The submission process involves a two-stepped approach: Applicants should first submit a technical proposal via email, following a specified format. This proposal should outline their capabilities and how they meet the specific requirements. Changes to the technical proposal can be made at any time before the unspecified deadline. It is the responsibility of the applicant to ensure their proposal remains up-to-date. Evaluation Criteria The evaluation of applications will give priority to suppliers who can demonstrate an understanding of and ability to meet the detailed requirements outlined in the solicitation. The USDA will assess applicants' capacity to adhere to the FPPS specifications, their experience in the industry, and their proposed production plans. Additionally, the USDA will conduct a food defense audit of each applicant's Food Defense Plan before opening bids. Contact Information For further clarification or questions, interested parties can contact Mark Lemon at mark.lemon@usda.gov. Suppliers should carefully consider the comprehensive requirements before submitting their applications. The solicitation, with its detailed specifications, serves as a comprehensive guide for applicants.
    RRPV Solicitation Summary: NextGen Oral Formulation Vaccines for COVID-19
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the Office of Assistant Secretary for Preparedness and Response (BARDA), is seeking proposals for the development of NextGen Oral Formulation Vaccines for COVID-19 through a Request for Project Proposals (RPP) issued via the Rapid Response Partnership Vehicle (RRPV) Consortium. The primary objective of this solicitation is to advance oral vaccine platforms and technologies into a proof-of-concept Phase 1 clinical trial, enhancing the understanding of their potential and improving COVID-19 solutions to bolster preparedness against future health security threats. This initiative is critical in the ongoing efforts to combat COVID-19 and prepare for similar health crises. Interested parties can access the full RPP and additional consortium information at www.rrpv.org, and inquiries can be directed to Rebecca Harmon at rebecca.harmon@ati.org.
    RFI-Transportable Patient Biocontainment, Isolation, and Quarantine Systems
    Active
    Dept Of Defense
    The U.S. Department of Defense seeks innovative solutions for its Joint Project Manager for Chemical, Biological, Radiological, and Nuclear Protection (JPM CBRN Protection) program. The requirement is for transportable biocontainment, isolation, and quarantine (BIQ) systems, or components thereof, to be used across various platforms such as ships, aircraft, wheeled vehicles, and field deployable systems. These systems are crucial in preventing the spread of biological threats and addressing public health emergencies. Modularity, scalability, and compatibility with existing healthcare infrastructure are key attributes the government seeks, along with strict adherence to safety and quality standards. The focus is on finding deployable and sustainable solutions to contain hazardous pathogens, with the potential for multiple system applications across different platforms. An upcoming Innovation Day on October 9th, 2024, will provide an opportunity for interested parties to discuss their technologies and gain a deeper understanding of the government's requirements. Per the request, responses must be submitted via email to Brian Liska at brian.liska@usmc.mil by November 8th, 2024, at 5:00 p.m. EST. The contact email is brian.liska@usmc.mil, and further details can be found on the SAM.gov website.
    BPA for Theileria equi and Babesia caballi test kits at NVSL Ames, IA
    Active
    Agriculture, Department Of
    Presolicitation notice from the Department of Agriculture, Animal and Plant Health Inspection Service, for a multiple-award firm fixed-price, Blanket Purchase Agreement (BPA) commercial supply contract to obtain Theileria equi and Babesia caballi test kits. The test kits are used for in vitro diagnostic purposes and are typically used to detect and diagnose Theileria equi and Babesia caballi infections in animals. The BPA will be for 5 years with an estimated quantity of 400 test kits per year. This procurement is set aside for small businesses and will be issued on or about 01/19/2024. Interested parties should monitor the site for the solicitation and amendments. For more information, contact Mario Garcia, Contract Specialist, at mario.garcia2@usda.gov.
    Pegfilgrastim with VMI
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services (HHS) is seeking proposals for the procurement of Pegfilgrastim 6MG/.06ML (injection solution, syringe, or autoinjector) along with Vendor Managed Inventory (VMI) services to support the Strategic National Stockpile (SNS). This procurement aims to ensure a reliable supply of essential pharmaceuticals for public health emergencies, with a contract duration of five years, including a one-year base period and four optional ordering periods. The initial quantity required is 18,300 units, with potential increases based on public health needs, emphasizing the importance of maintaining robust health security capabilities. Interested contractors must submit their proposals by October 2, 2024, and can direct inquiries to LaMonica Norwood at OSContracting@hhs.gov.